BRPI0703127A2 - composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia - Google Patents
composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhiaInfo
- Publication number
- BRPI0703127A2 BRPI0703127A2 BRPI0703127-0A BRPI0703127A BRPI0703127A2 BR PI0703127 A2 BRPI0703127 A2 BR PI0703127A2 BR PI0703127 A BRPI0703127 A BR PI0703127A BR PI0703127 A2 BRPI0703127 A2 BR PI0703127A2
- Authority
- BR
- Brazil
- Prior art keywords
- spp
- bacteria
- acute
- treatment
- caused
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- 230000001154 acute effect Effects 0.000 title abstract 3
- 230000001684 chronic effect Effects 0.000 title abstract 3
- 241000233866 Fungi Species 0.000 title abstract 2
- 208000005141 Otitis Diseases 0.000 title abstract 2
- 208000019258 ear infection Diseases 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 241000282465 Canis Species 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 241000186216 Corynebacterium Species 0.000 abstract 1
- 241001480036 Epidermophyton floccosum Species 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 241000893980 Microsporum canis Species 0.000 abstract 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 abstract 1
- 241000588769 Proteus <enterobacteria> Species 0.000 abstract 1
- 241000588770 Proteus mirabilis Species 0.000 abstract 1
- 241000588767 Proteus vulgaris Species 0.000 abstract 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract 1
- 241000191940 Staphylococcus Species 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 241000191980 Staphylococcus intermedius Species 0.000 abstract 1
- 241000194017 Streptococcus Species 0.000 abstract 1
- 241000193996 Streptococcus pyogenes Species 0.000 abstract 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 abstract 1
- 241000223229 Trichophyton rubrum Species 0.000 abstract 1
- 239000003470 adrenal cortex hormone Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 229960003405 ciprofloxacin Drugs 0.000 abstract 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 abstract 1
- 229940043075 fluocinolone Drugs 0.000 abstract 1
- 229960004125 ketoconazole Drugs 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 229940007042 proteus vulgaris Drugs 0.000 abstract 1
- 239000003306 quinoline derived antiinfective agent Substances 0.000 abstract 1
- 229940076156 streptococcus pyogenes Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIçãO PARA O TRATAMENTO DE OTITES AGUDAS OU CRÈNICAS CAUSADAS POR FUNGOS E/OU BACTéRIAS EM ANIMAIS DE COMPANHIA. A presente invenção refere-se a uma nova associação composta por um antibiótico da classe das quinolonas, denominado Ciprofloxacina; um antifúngico azólico - Cetoconazol; um antiinflamatório corticóide - Fluocinolona e um anestésico local da classe das aminas - Lidocaína, destinada para o tratamento das otites agudas ou crónicas em animais de companhia, particularmente cães e gatos, causadas por bactérias: Staphylococcus intermedius, Staphylococcus aureus, Staphylococcus spp, Streptococcus spp, Streptococcus pyo genes, Proteus mirabilis, Proteus vulgaris, Proteus spp, Pseudomonas aeruginosa, Escherichia coli, Corynebacterium spp e demais bactérias. Fungos. Mailassezia pachydermatis (Pityrosporum canis), Epidermophyton floccosum, Microsporum canis, Trichophyton rubrum, Trichophyton mentagrophytes, Candida spp entre outros.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0703127-0A BRPI0703127A2 (pt) | 2007-08-22 | 2007-08-22 | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
| PCT/BR2008/000248 WO2009023943A1 (en) | 2007-08-22 | 2008-08-18 | Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals |
| US12/671,750 US20110275602A1 (en) | 2007-08-22 | 2008-08-18 | Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals |
| BRPI0806095-9A BRPI0806095A2 (pt) | 2007-08-22 | 2008-08-18 | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0703127-0A BRPI0703127A2 (pt) | 2007-08-22 | 2007-08-22 | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0703127A2 true BRPI0703127A2 (pt) | 2009-04-14 |
Family
ID=40377770
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0703127-0A BRPI0703127A2 (pt) | 2007-08-22 | 2007-08-22 | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
| BRPI0806095-9A BRPI0806095A2 (pt) | 2007-08-22 | 2008-08-18 | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0806095-9A BRPI0806095A2 (pt) | 2007-08-22 | 2008-08-18 | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20110275602A1 (pt) |
| BR (2) | BRPI0703127A2 (pt) |
| WO (1) | WO2009023943A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130079353A1 (en) | 2009-12-22 | 2013-03-28 | Karsten Gülow | Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| EP2654637A1 (en) | 2010-12-23 | 2013-10-30 | Boehringer Ingelheim Vetmedica GmbH | Kit-in-parts for cleaning and treating ears of companion animals |
| JP6815649B2 (ja) * | 2015-03-31 | 2021-01-20 | 国立研究開発法人産業技術総合研究所 | インターフェロンαの経口投与による慢性難治性外耳炎治療効果 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070054844A1 (en) * | 2003-08-20 | 2007-03-08 | Fairfield Clinical Trials, Llc | Method for treating otitis externa |
| US20050043251A1 (en) * | 2003-08-20 | 2005-02-24 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
| US8030362B2 (en) * | 2003-12-12 | 2011-10-04 | Otic Pharma Ltd. | Compositions for treatment of ear disorders and methods of use thereof |
| PL1776109T3 (pl) * | 2004-08-13 | 2009-06-30 | Schering Plough Ltd | Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid |
-
2007
- 2007-08-22 BR BRPI0703127-0A patent/BRPI0703127A2/pt not_active Application Discontinuation
-
2008
- 2008-08-18 WO PCT/BR2008/000248 patent/WO2009023943A1/en not_active Ceased
- 2008-08-18 BR BRPI0806095-9A patent/BRPI0806095A2/pt not_active Application Discontinuation
- 2008-08-18 US US12/671,750 patent/US20110275602A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009023943A1 (en) | 2009-02-26 |
| WO2009023943A8 (en) | 2009-10-15 |
| US20110275602A1 (en) | 2011-11-10 |
| BRPI0806095A2 (pt) | 2009-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016006589A2 (pt) | composição, e composição de vacina | |
| Thalij | Biosynthesis of zinc oxide nanoparticles and assay of antibacterial activity | |
| NO20081000L (no) | Anvendelse av aureolysininhibitor for behandling av inflammatoriske hudsykdommer karakterisert ved kolonisering med Staphylococcus Aureus | |
| PH12021551143A1 (en) | Novel imidazole derivative | |
| NZ713357A (en) | Antimicrobial compounds and methods of making and using the same | |
| BR112022008938A2 (pt) | Derivados de 1-aminossulfonil-2-carboxipirrol como inibidores de metalo-beta-lactamase | |
| Downes et al. | Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion | |
| Jindal et al. | Microbiologic spectrum and susceptibility of isolates in acute postcataract surgery endophthalmitis: are they same as they were more than a decade ago? | |
| Tabatabaei et al. | The in vitro study of antimicrobial effect of Teucrium polium extract on infectious microorganisms | |
| Vidal et al. | Chemical composition, antibacterial and modulatory action of the essential oil of Croton rhamnifolioides leaves Pax and Hoffman | |
| Soyoung et al. | Identification and antimicrobial susceptibility of bacteria isolated from dogs with chronic otitis externa | |
| WO2014057415A3 (en) | Inhibitors of dna gyrase for the treatment of bacterial infections | |
| BRPI0806095A2 (pt) | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia | |
| Aonofriesei | Effect of methylpyrazoles and coumarin association on the growth of Gram-negative bacteria | |
| Ebrahimi et al. | Antimicrobial activity of rosemary essential oil and its interaction with common therapeutic antibiotics on some gram positive and gram negative bacteria | |
| Seier-Petersen | Development of bacterial resistance to biocides and antimicrobial agents as a consequence of biocide usage | |
| Rezaii | The antibacterial effect of iron oxide and graphene oxide nanoparticles and their nanocomposites against Escherichia coli and Staphylococcus aureus bacteria | |
| Olga et al. | Chlorhexidine for routine PD catheter exit-site care | |
| PL445342A1 (pl) | Nowy peptyd antybakteryjny oraz jego zastosowanie | |
| RU2020123463A (ru) | Вакцина для профилактики мастита у крупного рогатого скота | |
| Pestova et al. | MICROBIAL ASSOCIATIONS IN PATIENTS WITH CHRONIC RHINOSINUSITIS | |
| Bajon et al. | Antibacterial activity of Sandoricum koetjape (Santol) leaf ethanolic extract against Staphylococcus aureus and Escherichia coli | |
| Antonio et al. | In vitro antimicrobial activity of a black currant oil based shampoo versus a chlorhexidine 4% shampoo on bacteria strains isolated from canine pyoderma: A comparative study | |
| Tomar et al. | Assessment of antimicrobial activity of pomegranate leaf extract against bacterial isolates of otitis externa and diarrhea of dogs | |
| NOZOHOUR et al. | ANTI-BACTERIAL EFFECT OF ALCOHOLIC EXTRACT OF PINE ON BACTERIA ISOLATED FROM URINE OF PATIENTS WITH URINARY TRACT INFECTION–GENITAL |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B11K | Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved |
Free format text: PRIORIDADE INTERNA DO PEDIDO PI 0806095-9. |
|
| B03G | Publication of an application: publication cancelled [chapter 3.7 patent gazette] |
Free format text: REFERENTE A RPI 1997 DE 14/04/2009. |
|
| B03F | Publication of an application: publication of application definitely dismissed [chapter 3.6 patent gazette] |